Great Valley Advisor Group’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Great Valley Advisor Group's UNCY Position: Q3 2026 in Review
Great Valley Advisor Group opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 16,198 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #1067 among its holdings.
93 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Great Valley Advisor Group held 16,198 shares of Unicycive Therapeutics worth $76K as of Q3 2026.
- Unicycive Therapeutics was a new Great Valley Advisor Group position in Q3 2026.
- Unicycive Therapeutics made up ﹤0.01% of Great Valley Advisor Group's portfolio in Q3 2026, its #1067 holding.
- 93 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Great Valley Advisor Group's 13F filing for Q3 2026, filed 9 Nov 2026.